A Phase 2 Study of JADE101 in Participants With Immunoglobulin A Nephropathy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to IgA Nephropathy
Related studies linked through entity extraction aliases.
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
IgA Nephropathy Insights From Treatment Experience Among Patients Receiving Iptacopan and/or Atrasentan Using Primary Data Collection
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Managed Access Programs for EXV811, Atrasentan
- Status
- AVAILABLE
- Phase
- N/A
Study of BHV-1400 in IgA Nephropathy
- Status
- RECRUITING
- Phase
- PHASE1
A Clinical Study to Evaluate the Effect of Food on the Pharmacokinetic Profiles of HRS-5965 Capsules in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Nefecon and Ambrisentan in IgA Nephropathy
- Status
- RECRUITING
- Phase
- PHASE4
Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Study of CM313 in Subject With IgA Nephropathy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Probiotics in IgA Nephropathy
- Status
- RECRUITING
- Phase
- NA
Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
- Status
- RECRUITING
- Phase
- PHASE4
IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy Patients
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?
- Status
- RECRUITING
- Phase
- PHASE4
Effect of Finerenone in IgA Nephropathy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA Nephropathy
- Status
- COMPLETED
- Phase
- N/A
Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
- Status
- WITHDRAWN
- Phase
- PHASE2
The Effect of OSA on Severity and Prognosis of Patients With IgAN
- Status
- NOT_YET_RECRUITING
- Phase
- N/A